(lp0
S"Why Portola Pharmaceuticals Inc Stock Surged Higher Today Motley Fool - Dec 23, 2016 Shares of clinical stage anticoagulant specialist Portola Pharmaceuticals Inc  rose 33.5% at the end of Friday's session.Portola Shares Surge on Application Acceptance - Wall Street Journal"
p1
aS'Mardi Dier Sells 10235 Shares of Portola Pharmaceuticals Inc  Stock Chaffey Breeze - Mar 16, 2017 Portola Pharmaceuticals logo Portola Pharmaceuticals Inc  VP Mardi Dier sold 10,235 shares of Portola Pharmaceuticals stock in a transaction that occurred on Wednesday, March 15th.'
p2
aS"Today's Brokerage Rating: Regal Entertainment Group , Portola ... StockNewsJournal - 17 hours ago Portola Pharmaceuticals, Inc. , maintained return on investment for the last twelve months at -74.02, higher than what Reuters data shows regarding industry's average."
p3
aS"Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial ... GlobeNewswire  - Feb 28, 2017 Collaboration and license revenue earned under Portola's collaboration and license agreements with Bristol-Myers Squibb Company and Pfizer, Bayer Pharma and Janssen Pharmaceuticals, Daiichi Sankyo and Dermavant Sciences was $13.7 million for the&nbsp;...Portola Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 01 - Equities.com"
p4
aS"Portola Pharmaceuticals Announces Betrixaban and AndexXa (andexanet alfa ... GlobeNewswire  - Mar 7, 2017 SOUTH SAN FRANCISCO, Calif., March 07, 2017  -- Portola Pharmaceuticals Inc.  today announced that new data from the pivotal Phase 3 APEX Study of the Company's investigational drug betrixaban will be&nbsp;...Rating Change on Portola Pharmaceuticals, Inc.  - Energy Index"
p5
aS"Portola Pharmaceuticals to Announce Fourth Quarter and Year-End 2016 Financial ... Yahoo Finance - Feb 21, 2017 21, 2017  -- Portola Pharmaceuticals, Inc.  announced today that it will host a webcast and conference call to discuss the Company's financial results for the quarter and year ended December 31, 2016, and provide a general&nbsp;...Portola Pharmaceuticals Inc.  Breaks into New 52-Week High on February ... - Equities.com"
p6
aS"The Charles J. Homcy Sells 50000 Shares of Portola Pharmaceuticals Inc (PTLA ... Petro Global News 24 - 21 hours ago Portola Pharmaceuticals Inc  Director Charles J. Homcy sold 50,000 shares of the business's stock in a transaction dated Wednesday, March 15th.State Street Corp Buys 34027 Shares of Portola Pharmaceuticals Inc  - The Cerbat GemPortola Pharmaceuticals Inc  Lowered to Buy at Vetr Inc. - Sports Perspectives"
p7
aS'Portola Pharmaceuticals Reaches Analyst Target Price Nasdaq - Feb 22, 2017 In recent trading, shares of Portola Pharmaceuticals, Inc.  have crossed above the average analyst 12-month target price of $32.33, changing hands for $32.66/share.'
p8
aS'Option Market Alert: Portola Pharmaceuticals Inc Implied Price Swing Hits An ... CML News - Mar 19, 2017 No Risk Alert Here: Before we dive into any analysis we simply note that Portola Pharmaceuticals Inc  risk is neither elevated nor depressed.'
p9
aS"Portola Pharmaceuticals Inc.  Breaks into New 52-Week High on March 15 ... Equities.com - Mar 15, 2017 Shares of Portola Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $40.92. Shares closed at $40.86 after opening at $39.59 for a move of 3.26%.Portola Pharmaceuticals, Inc. : Important Trade and Target Levels ... - Post AnalystToday's Brokerage Rating: HealthSouth Corporation , Portola ... - StockNewsJournal"
p10
a.